Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$103K Sell
23,205
-548
-2% -$3K 1.94% 17
2026
Q1
$109K Sell
23,753
-15,009
-39% -$88.4K 1.11% 43
2025
Q4
$313K Buy
+38,762
New +$307K 0.16% 248
2025
Q2
Sell
-12,396
Closed -$108K 417
2025
Q1
$108K Buy
+12,396
New +$129K 0.15% 245

Other funds holding SNAP

PharVision Advisers's SNAP Position: Q2 2026 in Review

PharVision Advisers reduced its Snap (SNAP) stake by 2.3% in Q2 2026, selling an estimated $3K and leaving 23,205 shares worth $103K. The position accounts for 1.94% of the portfolio, ranked #17.

PharVision Advisers first reported a position in SNAP in Q1 2025 and has held it in 4 quarters since. The position peaked at $313K in Q4 2025. 534 funds tracked by Wall St. Rank hold SNAP as of Q2 2026.

  • PharVision Advisers held 23,205 shares of Snap worth $103K as of Q2 2026.
  • PharVision Advisers sold 548 Snap shares in Q2 2026, an estimated $3K.
  • Snap made up 1.94% of PharVision Advisers's portfolio in Q2 2026, its #17 holding.
  • PharVision Advisers first reported a position in Snap in Q1 2025 and has held it in 4 quarters since.
  • PharVision Advisers's Snap position peaked at $313K in Q4 2025.
  • 534 funds tracked by Wall St. Rank held Snap as of Q2 2026.

Based on PharVision Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.